Discontinuation report PMS-ZOLEDRONIC ACID
| Report ID | 6088 |
| Drug Identification Number | 02403056 |
| Brand name | PMS-ZOLEDRONIC ACID |
| Common or Proper name | ZOLEDRONIC ACID |
| Company Name | PHARMASCIENCE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5 mL |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-03-23 |
| Remaining supply date | 2017-03-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-05-03 | English | Compare |
| v2 | 2017-04-07 | French | Compare |
| v1 | 2017-04-07 | English | Compare |
Showing 1 to 3 of 3